Helminthic therapy and aging

    From Helminthic Therapy wiki

    Hosting helminths could be key to living longer with greater freedom from chronic disease.

    The following study was the first of its kind to report that weekly administration of the helminth-derived product, ES-62, improved late-life health and increased lifespan (+12%, median lifespan) in a mouse model of high-calorie diet-accelerated aging. This suggests that the anti-inflammatory effects of helminthic therapy can exert protective effects even in later life.

    Lipopolysaccharide (LPS)[edit | edit source]

    Lipopolysaccharide (LPS), now more commonly known as endotoxin, is a collective term for components of the outermost membrane of the cell envelope of gram-negative bacteria, such as E. coli and Salmonella with a common structural architecture.

    Excessive LPS in the blood, endotoxemia, may cause a highly lethal form of sepsis known as endotoxic septic shock. Recent research indicates that even small LPS exposure is associated with autoimmune diseases and allergies. High levels of LPS in the blood can lead to metabolic syndrome, increasing the risk of conditions like diabetes, heart disease and liver problems.

    LPS binds Toll like receptor 4 (TLR-4) which is present in various organs and activates an inflammation process.

    Helminths can act in 4 different ways:

    • reduce the gram-negative bacteria in the microbiota
    • fix leaky gut
    • maybe send peptides that prevent interaction with the toll-like receptor (TLR) 4/MD2/CD14 complex [2]. (This is yet to be confirmed with therapeutic helminths.)
    • the immunomodulatory effect

    Relevant papers:

    Quotein.gif
    This peptide adopts an amphipathic helix structure and, like LL-37, can bind to Escherichia coli lipopolysaccharide (LPS) to prevent its interaction with the toll-like receptor (TLR) 4/MD2/CD14 complex on macrophages

    See also Helminthic therapy and sepsis